11:04 AM EDT, 10/09/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.72% to 1,580.25 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and biotech firm Evaxion ( EVAX ) , which advanced 10% and 1.8% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and biopharmaceutical company DBV Technologies ( DBVT ) , which increased 1.6% and 1.2% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and internet advertising firm, Criteo ( CRTO ) , which lost 5.8% and 3.3% respectively. They were followed by telecommunications company Ericsson (ERIC) and medical device maker EDAP TMS ( EDAP ) , which dropped 3.1% and 2.3% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company Silence Therapeutics ( SLN ) , which surged 28% and 11% respectively. They were followed by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Mereo BioPharma Group ( MREO ) , which rose 6.3% and 4% respectively.

The decliners from the UK and Ireland were led by lender HSBC ( HSBC ) and communications company WPP ( WPP ) , which fell 4.8% and 3.8% respectively. They were followed by lender Lloyds Banking Group ( LYG ) and insurance company Prudential (PUK), which were down 2.5% and 1.7% respectively.